ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
2026 ARDC Annual Survey is now open!

The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your interaction with the ARDC and use of our national research infrastructure and services. The survey will take approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure services including Reasearch Link Australia.

We will use the information you provide to improve the national research infrastructure and services we deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research Infrastructure Strategy (NCRIS) program.

Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.

Complete the 5 min survey now by clicking on the link below.

Take Survey Now

Thank you.

  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : Allergic aspergillosis
Scheme : Project Grants
Clear All
Filter by Field of Research
Respiratory Diseases (4)
Allergy (3)
Medical and Health Sciences not elsewhere classified (2)
Cellular Immunology (1)
Clinical Sciences not elsewhere classified (1)
Epidemiology (1)
Medical Virology (1)
Preventive Medicine (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (14)
Filter by Status
Closed (14)
Filter by Scheme
Project Grants (14)
Filter by Country
Australia (5)
Filter by Australian State/Territory
VIC (4)
ACT (2)
QLD (1)
  • Researchers (0)
  • Funded Activities (14)
  • Organisations (0)
  • Funded Activity

    Determining The Role Of Vitamin D In The Development Of Asthma And Allergic Diseases In High Risk Families

    Funder
    National Health and Medical Research Council
    Funding Amount
    $351,127.00
    Summary
    Allergic diseases like asthma, eczema and hay-fever, prevent our children from getting a healthy start to life, and we don’t know how to prevent these conditions. Vitamin D levels may be critical in the development of childhood asthma and allergies, and they can be easily modified! Using a group of 620 children who we have followed for 20 years, we will identify the role of vitamin D levels in the development of allergic conditions, and factors that modify these relationships.
    More information
    Funded Activity

    A Randomised Controlled Trial To Prevent Eczema, Food Allergy And Sensitisation Using A Skin Barrier Improvement Strategy

    Funder
    National Health and Medical Research Council
    Funding Amount
    $878,163.00
    Summary
    In this world first study, we will test if building the infant skin barrier by using daily regular skin care treatment can reduce the incidence of eczema. If successful, this trial will alter infant skin care practices and reduce the burden of allergic diseases in our community. Furthermore, as infants with eczema having a poor skin barrier, which possibly increases their risk of developing sensitisation, we will test if this intervention reduces the risk of food allergy.
    More information
    Funded Activity

    Regulation Of Skin Inflammation By Mechanosensor YAP

    Funder
    National Health and Medical Research Council
    Funding Amount
    $612,566.00
    Summary
    Atopic diseases are a significant public health burden in the developed world. The economic cost of care and reduced quality of life for asthmatics necessitates that greater action and resources be directed toward the treatment and prevention of the atopic march. This project aims to identify molecular regulators of this disease process which may identify novel targets for therapy and early intervention.
    More information
    Funded Activity

    Targeting MiRNA To Inhibit Leukocyte Differentiation: A Novel Anti-inflammatory Approach For The Treatment Of Asthma

    Funder
    National Health and Medical Research Council
    Funding Amount
    $601,386.00
    Summary
    In asthma, the symptoms are caused by an allergic reaction in the lung and the production of inflammatory cells whose maturation is guided by tiny molecules called “microRNAs”. The critical microRNAs will be identified and strategies to block their function developed and tested for their ability to inhibit allergic inflammation to evaluate this approach as a new treatment for asthma.
    More information
    Funded Activity

    Understanding The Mechanisms Of Steroid Resistant Inflammatory Pathways In Mouse Models Of Asthma: Potential New Treatment Approaches

    Funder
    National Health and Medical Research Council
    Funding Amount
    $523,694.00
    Summary
    Steroids are used to treat asthma but some patients are resistant to therapy, and there is no effective treatment. Such patients suffer greater morbidity and mortality, and the heath care cost for clinical management is a significant economic burden. In this project we will obtain a better understanding of the mechanisms that regulate steroid-resistant components of disease, which control inflammation and narrowing of the airway. These studies will be central to the development of new therapies.
    More information
    Funded Activity

    Quantitative Survival Regulation By T Cells

    Funder
    National Health and Medical Research Council
    Funding Amount
    $372,049.00
    Summary
    During an immune response a white blood cell, the T lymphocyte, receives a series of signals that manipulate cell survival and proliferation. The team at WEHI will identify the effects of key signals on the molecular control of T cell survival. The results will be used to test a new method for inducing tolerance and dampening unwanted immune responses, such as during tissue graft rejection and autoimmunity.
    More information
    Funded Activity

    Phenotypic And Functional Characterisation Of CD4 T Helper 22 Cells And Their Role In The Regulation Of Chronic Allergic Disease Of The Lung And Skin

    Funder
    National Health and Medical Research Council
    Funding Amount
    $714,061.00
    Summary
    Allergic inflammatory diseases such as asthma and allergic dermatitis are major health problems in our community that lead to poor quality of life. These diseases are induced by activation of immune cells known as T helper (Th) lymphocytes. Recently Th22 cells have been identified in patients with allergic diseases. In this study we will, for the first time, characterise these cells and determine their role in the processes that lead to chronic inflammation in asthma and allergic dermatitis.
    More information
    Funded Activity

    A New And Effective Approach To Reversal Of Allergic Airways Inflammation By Turning Off Allergic Responses

    Funder
    National Health and Medical Research Council
    Funding Amount
    $393,514.00
    Summary
    Inflammatory diseases like asthma develop from misdirected immune responses. The ultimate goal of therapeutic strategies is to remove or inactivate the cells that cause inflammation while leaving other cells, for example, those required for protection from infectious diseases and tumours, unaffected. Here we propose to test a new way of turning off the inappropriate immune reaction with the goal of preventing or reversing asthma.
    More information
    Funded Activity

    Towards Reducing The Susceptibility Of “high Risk” Infants To Allergic Asthma By Therapeutic Modulation Of Immunoregulatory Functions In The Pregnant Mother.

    Funder
    National Health and Medical Research Council
    Funding Amount
    $445,681.00
    Summary
    This project will deliver information in relation to the potential use and underlying modes of action of a therapeutic agent fed to pregnant mothers at high risk for atopic children, to protect against allergic asthma development in their offspring. Furthermore, the project will address the benefits of this therapeutic agent in relation to protection against inflammation induced preterm birth.
    More information
    Funded Activity

    Transition From Childhood To Adult Asthma: Predicting Persistent And Adult-onset Asthma In Young Adults In The Raine Longitudinal Birth Cohort

    Funder
    National Health and Medical Research Council
    Funding Amount
    $1,018,496.00
    Summary
    While many children grow out of their asthma a significant number continue to have asthma in later life. The Raine community birth cohort has followed newborn infants from birth and has contributed to our understanding of how asthma develops throughout childhood. The proposed project aims to assess those factors that contribute to the persistence of asthma throughout childhood in into early adult life in the as well as investigate the predictors of adult onset asthma at 23 years of age.
    More information

    Showing 1-10 of 14 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback